Back
  1. Home
  2. Profile of Vyron GORGOGIETAS (Unilu)
Profil

GORGOGIETAS Vyron

University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience

Main Referenced Co-authors
ARENA, Giuseppe  (1)
Brockmann, Kathrin (1)
Drwesh, Layla (1)
FERRANTE, Daniele  (1)
Fitzgerald, Julia C (1)
Gasser, Thomas (1)
Main Referenced Keywords
iPSC (1); MIRO1 (1); Mitochondria (1); Parkinson's disease (1);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) (1)
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) (1)
Luxembourg Centre for Systems Biomedicine (LCSB): Molecular & Functional Neurobiology (Grünewald Group) (1)
Main Referenced Disciplines
Neurology (1)
Genetics & genetic processes (1)

Publications (total 1)

The most downloaded
42 downloads
Drwesh, L., ARENA, G., Merk, D. J., FERRANTE, D., GORGOGIETAS, V., Gasser, T., GRÜNEWALD, A., MAY, P., Brockmann, K., KRÜGER, R., Wüst, R., Gloeckner, C. J., & Fitzgerald, J. C. (15 September 2025). Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker. NPJ Parkinson's Disease, 11 (1), 270. doi:10.1038/s41531-025-01115-8 https://hdl.handle.net/10993/65823

The most cited

1 citations (Scopus®)

Drwesh, L., ARENA, G., Merk, D. J., FERRANTE, D., GORGOGIETAS, V., Gasser, T., GRÜNEWALD, A., MAY, P., Brockmann, K., KRÜGER, R., Wüst, R., Gloeckner, C. J., & Fitzgerald, J. C. (15 September 2025). Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker. NPJ Parkinson's Disease, 11 (1), 270. doi:10.1038/s41531-025-01115-8 https://hdl.handle.net/10993/65823

Drwesh, L., ARENA, G., Merk, D. J., FERRANTE, D., GORGOGIETAS, V., Gasser, T., GRÜNEWALD, A., MAY, P., Brockmann, K., KRÜGER, R., Wüst, R., Gloeckner, C. J., & Fitzgerald, J. C. (15 September 2025). Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker. NPJ Parkinson's Disease, 11 (1), 270. doi:10.1038/s41531-025-01115-8
Peer Reviewed verified by ORBi

Contact ORBilu